Diversified Healthcare Analyst Ratings
Diversified Healthcare Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/05/2023 | 71.1% | B. Riley Securities | $4 → $4.5 | Maintains | Buy |
12/30/2021 | 128.14% | B. Riley Securities | $5 → $6 | Maintains | Buy |
07/29/2021 | 80.61% | Morgan Stanley | $5 → $4.75 | Maintains | Equal-Weight |
03/15/2021 | 90.11% | Morgan Stanley | $4.75 → $5 | Maintains | Equal-Weight |
02/02/2021 | 80.61% | Morgan Stanley | $5 → $4.75 | Maintains | Equal-Weight |
11/16/2020 | 23.57% | B of A Securities | $2.75 → $3.25 | Maintains | Underperform |
10/09/2020 | 14.07% | Morgan Stanley | $2.75 → $3 | Maintains | Equal-Weight |
06/22/2020 | 52.09% | Wells Fargo | $3.5 → $4 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/19/2020 | 4.56% | Morgan Stanley | $8 → $2.75 | Maintains | Equal-Weight |
05/11/2020 | 166.16% | B. Riley Securities | $10 → $7 | Maintains | Buy |
03/04/2020 | 280.23% | B. Riley Securities | $12 → $10 | Maintains | Buy |
01/17/2020 | 242.21% | Wells Fargo | → $9 | Downgrades | Overweight → Equal-Weight |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
09/05/2023 | 71.1% | B.莱利证券 | $4→$4.5 | 维护 | 买 |
2021年12月30日 | 128.14% | B.莱利证券 | $5→$6 | 维护 | 买 |
07/29/2021 | 80.61% | 摩根士丹利 | $5→$4.75 | 维护 | 等重 |
03/15/2021 | 90.11% | 摩根士丹利 | $4.75→$5 | 维护 | 等重 |
02/02/2021 | 80.61% | 摩根士丹利 | $5→$4.75 | 维护 | 等重 |
11/16/2020 | 23.57% | B of A证券 | $2.75→$3.25 | 维护 | 表现不佳 |
10/09/2020 | 14.07% | 摩根士丹利 | $2.75→$3 | 维护 | 等重 |
06/22/2020 | 52.09% | 富国银行 | $3.5→$4 | 维护 | 等重 |
06/08/2020 | - | JMP证券 | 恢复 | →市场表现 | |
2020/05/19 | 4.56% | 摩根士丹利 | $8→$2.75 | 维护 | 等重 |
05/11/2020 | 166.16% | B.莱利证券 | $10→$7 | 维护 | 买 |
03/04/2020 | 280.23% | B.莱利证券 | $12→$10 | 维护 | 买 |
2020/01/17 | 242.21% | 富国银行 | →$9 | 评级下调 | 超重→等重 |
What is the target price for Diversified Healthcare (DHC)?
多元化医疗(DHC)的目标价格是多少?
The latest price target for Diversified Healthcare (NASDAQ: DHC) was reported by B. Riley Securities on September 5, 2023. The analyst firm set a price target for $4.50 expecting DHC to rise to within 12 months (a possible 71.10% upside). 1 analyst firms have reported ratings in the last year.
B·莱利证券于2023年9月5日报道了多元化医疗(纳斯达克:DHC)的最新目标价。这家分析公司将目标价定为4.50美元,预计DHC将在12个月内上涨至71.10%。1家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Diversified Healthcare (DHC)?
多元化医疗(DHC)的最新分析师评级是多少?
The latest analyst rating for Diversified Healthcare (NASDAQ: DHC) was provided by B. Riley Securities, and Diversified Healthcare maintained their buy rating.
分析师对多元化医疗(纳斯达克:DHC)的最新评级由B.莱利证券提供,多元化医疗维持买入评级。
When is the next analyst rating going to be posted or updated for Diversified Healthcare (DHC)?
多元化医疗(DHC)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Diversified Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Diversified Healthcare was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
分析师在进行了广泛的研究后得出股票评级,其中包括查阅公共财务报表,与Diversified Healthcare的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。对多元化医疗的上一次评级是在2023年9月5日提交的,所以你应该预计下一次评级将在2024年9月5日左右的某个时候公布。
Is the Analyst Rating Diversified Healthcare (DHC) correct?
分析师对多元化医疗(DHC)的评级正确吗?
While ratings are subjective and will change, the latest Diversified Healthcare (DHC) rating was a maintained with a price target of $4.00 to $4.50. The current price Diversified Healthcare (DHC) is trading at is $2.63, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的多元化医疗(DHC)评级保持不变,目标价在4.00美元至4.50美元之间。多元化医疗(DHC)目前的交易价格为2.63美元,超出了分析师的预测区间。